tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares

Story Highlights
  • LTR Pharma has applied to list 82,508 new fully paid ordinary shares on the ASX.
  • The newly issued shares stem from exercised or converted securities, modestly expanding LTR Pharma’s quoted capital base.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares

Claim 50% Off TipRanks Premium

An announcement from LTR Pharma Limited ( (AU:LTP) ) is now available.

LTR Pharma Limited has applied to the ASX for quotation of an additional 82,508 fully paid ordinary shares. The new securities, issued on 21 January 2026 following the exercise or conversion of existing options or other convertible securities, will increase the company’s quoted capital base, modestly enhancing liquidity for shareholders and reflecting ongoing engagement with its equity financing structures.

More about LTR Pharma Limited

Average Trading Volume: 330,212

Technical Sentiment Signal: Buy

Current Market Cap: A$104.4M

For a thorough assessment of LTP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1